StonvexLoading…
StonvexStonvexStonvexCore line items from CPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.97M | $7.14M | $3.45M | $5.19M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $384.46M | $163.29M | $403.31M | $653.61M |
EPS (Diluted) | $3.54 | $1.50 | $3.70 | $6.04 |
Total Assets | $9.04B | $8.85B | $9.38B | $9.33B |
Total Liabilities | $4.60B | $4.10B | $4.33B | $4.27B |
Cash & Equivalents | $25.20M | $21.05M | $259.69M | $10.69M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 104.30M | 106.70M | 106.80M | 106.50M |